Compare EDIT & ALLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EDIT | ALLT |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.9M | 364.0M |
| IPO Year | 2016 | 2006 |
| Metric | EDIT | ALLT |
|---|---|---|
| Price | $2.91 | $7.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $5.30 | ★ $12.40 |
| AVG Volume (30 Days) | ★ 1.3M | 309.2K |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.50 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $31,937,000.00 | N/A |
| Revenue This Year | N/A | $15.84 |
| Revenue Next Year | N/A | $12.09 |
| P/E Ratio | ★ N/A | $469.21 |
| Revenue Growth | ★ 132.64 | N/A |
| 52 Week Low | $1.43 | $6.12 |
| 52 Week High | $4.54 | $11.92 |
| Indicator | EDIT | ALLT |
|---|---|---|
| Relative Strength Index (RSI) | 48.07 | 50.60 |
| Support Level | $2.77 | $7.52 |
| Resistance Level | $3.17 | $8.26 |
| Average True Range (ATR) | 0.22 | 0.37 |
| MACD | -0.04 | 0.05 |
| Stochastic Oscillator | 28.00 | 29.68 |
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.
Allot Ltd is a provider of security and network intelligence solutions for mobile, fixed, and cloud service providers, as well as enterprises. It offers network-based security solutions such as mobile security, DDoS protection, and IoT security, along with network analytics and traffic management. It focuses on expanding its Security-as-a-Service (SECaaS) offerings through the Allot Secure product family, which delivers unified protection for consumers and SMBs across mobile, fixed, and 5G networks. Its Allot Smart solutions enable service providers to analyze and manage network data, optimize performance, reduce costs, and enhance user experience. It has a customer base in Europe, which generates maximum revenue, as well as in Asia and Oceania, the Americas, the Middle East, and Africa.